Skip to content

Camillo Porta

Brigham and Women's Hospital

2 papers in the Anchorcite directory, published between 2008 and 2018, cited 18,007 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Josep Maria Llovet · 1 paper
  • Sergio Ricci · 1 paper
  • Vincenzo Mazzaferro · 1 paper
  • Philip a. Hilgard · 1 paper
  • Edward John Gane · 1 paper
  • Jean Frédéric Blanc · 1 paper
  • André Cosme de Oliveira · 1 paper
  • Armando Santoro · 1 paper

Papers

  1. Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations

    BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…

  2. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations

    BACKGROUND: Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS: We randomly assigned adults in…

Metadata from OpenAlex (CC0).